Authors

• Sumati Gupta (ORCID: https://orcid.org/0000-0001-6271-0831)
• Benjamin Louis Maughan (ORCID: https://orcid.org/0000-0002-0010-8551)
• Gliceida Galarza Fortuna (ORCID: https://orcid.org/0000-0002-1084-953X)
• Umang Swami (ORCID: https://orcid.org/0000-0003-3518-0411)
• Jonathan D. Tward (ORCID: https://orcid.org/0000-0001-7765-4473)
• Roger Li (ORCID: https://orcid.org/0000-0003-1274-7200)
• Brock O’Neil (ORCID: https://orcid.org/0000-0002-1497-5824)
• Shane Lloyd (ORCID: https://orcid.org/0000-0002-4235-7652)
• Alejandro Sánchez (ORCID: https://orcid.org/0000-0002-9054-7346)
• Tenzin Kunsang Phunrab
• Josiah Hawks (ORCID: https://orcid.org/0000-0001-9908-4598)
• Kenneth M. Boucher (ORCID: https://orcid.org/0000-0003-2833-0127)
• Rohit K. Jain (ORCID: https://orcid.org/0000-0002-9295-9360)
• Michael Adam Poch (ORCID: https://orcid.org/0000-0001-7339-8978)
• Christopher Dechet (ORCID: https://orcid.org/0000-0002-0534-6006)
• Neeraj Agarwal (ORCID: https://orcid.org/0000-0003-1076-0428)
• Julia Beck (ORCID: https://orcid.org/0009-0007-8556-1075)
• E. Schüetz
• Daniel Grass

Institutions

• Cornell University (US)
• University of Utah (US)
• Huntsman Cancer Institute (US)
• Moffitt Cancer Center (US)
• Utah Department of Health (US)
• University of Utah Health Care (US)
• Weill Cornell Medicine (US)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2025-03-01

DOI

https://doi.org/10.1136/jitc-2024-010572

Citations

3

Primary Topic

Bladder and Urothelial Cancer Treatments

Type

article

Field-Weighted Citation Impact

6.02

Funders

• Bristol-Myers Squibb
• Biomedical Laboratory Research and Development, VA Office of Research and Development
• Moffitt Cancer Center
• Huntsman Cancer Institute